Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001562180-19-000816)

Filing Details

Accession Number:: 0001562180-19-000816
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2019-02-07 16:30:49
Reporting Period:: 2019-01-29

Accepted Time:: 2019-02-07 16:30:49
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1100412	Array Biopharma Inc	ARRY	Pharmaceutical Preparations (2834)	841460811

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1714982	Gale Curtis Oltmans	C/O Array Biopharma, 3200 Walnut St. Boulder CO 80301	General Counsel	No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2019-01-29	11,100	$8.94	15,021	No	4	M	Direct
Common Stock	Acquisiton	2019-02-05	40,000	$8.94	55,021	No	4	M	Direct
Common Stock	Disposition	2019-02-05	40,000	$20.00	15,021	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2019-02-05	40,000	$0.00	40,000	$8.94

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
363,900		2027-08-15	No	4	M	Direct

Footnotes

These trades were made pursuant to a Rule 10b5-1 trading plan.
The option vests in four equal annual installments beginning August 15, 2018.